ClariVest Asset Management’s Perspective Therapeutics CATX Stock Holding History

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Shares Change %	Capital Flow	Portfolio Weight	Portfolio Position
2024 Q3	$540K	Hold	54,199	–	–	0.06%	344
2024 Q2	$540K	Buy	+54,199	New	+$540K	0.06%	344